Healthcare Sector

TGTX

Market Tracker

  • TGTX (Selected)

    TG Therapeutics, Inc.

TGTX Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

TGTX Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

TGTX Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

TGTX Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
06/18/2026 CALL $37.00 121 +92 +317.24%
05/15/2026 CALL $40.00 2,005 +84 +4.37%
05/15/2026 CALL $45.00 1,452 +40 +2.83%
05/15/2026 PUT $34.00 577 +29 +5.29%
08/21/2026 CALL $45.00 576 +27 +4.92%
05/15/2026 PUT $33.00 166 +25 +17.73%
05/15/2026 PUT $30.00 1,532 -9 -0.58%
05/15/2026 CALL $24.00 64 -10 -13.51%
05/15/2026 PUT $28.00 3,794 -10 -0.26%
05/15/2026 CALL $38.00 654 -29 -4.25%
05/15/2026 PUT $35.00 210 -73 -25.80%
05/15/2026 PUT $29.00 3,180 -100 -3.05%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

TGTX Major Holders

Name Pct Held Shares Total
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF 7.57% 10.99M 74.65M
Vanguard Total Stock Market Index Fund 2.60% 3.77M 25.62M
Vanguard Small-Cap Index Fund 2.27% 3.3M 22.4M
Vanguard Specialized-Health Care Fund 2.11% 3.07M 20.82M
iShares Russell 2000 ETF 1.98% 2.88M 19.55M
Smallcap World Fund 1.70% 2.45M 16.64M
Fidelity Advisor Biotechnology Fund 1.42% 2.05M 13.95M
Fidelity Select Portfolios - Biotechnology 1.42% 2.07M 14.03M
Vanguard Small-Cap Growth Index Fund 1.32% 1.92M 13.07M
Vanguard Extended Market Index Fund 1.23% 1.79M 12.13M
Fidelity Select Portfolios - Health Care 1.10% 1.6M 10.86M
Fidelity Growth Company Fund 1.04% 1.51M 10.27M
Fidelity Advisor Health Care Fund 0.76% 1.1M 7.47M
Fidelity Small Cap Growth Fund 0.71% 1.03M 7.01M
iShares Russell 2000 Growth ETF 0.71% 1.03M 7M
Fidelity Small Cap Index Fund 0.66% 960.14k 6.52M
Fidelity Central Investment Port-U.S. Equity Central Fd 0.60% 870k 5.91M
ACAP Strategic Fund 0.60% 865.46k 5.88M
Federated Hermes MDT Small Cap Core Fund 0.59% 857.01k 5.82M
Federated Hermes MDT Mid Cap Growth Fund 0.51% 734.84k 4.99M
Fidelity Extended Market Index Fund 0.47% 678.95k 4.61M
Fidelity Advisor Growth Opportunities Fund 0.46% 666.36k 4.52M

TGTX News

  • TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis

    02/08 05:17 pm

    GlobeNewswire Inc.

    Read more
  • Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Tumble Ahead Of SC Ruling On Trump's Tariffs— Wells Fargo, BP, WeRide In Focus (UPDATED)

    01/14 09:36 am

    Benzinga

    Read more
  • TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit

    11/10 05:00 pm

    GlobeNewswire Inc.

    Read more
  • TG Therapeutics Q2 Revenue Up 91%

    08/04 12:23 pm

    The Motley Fool

    Read more
  • TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

    05/05 07:00 am

    GlobeNewswire Inc.

    Read more
  • Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio?

    03/09 01:19 pm

    Benzinga

    Read more
  • TG Therapeutics to Participate in the Evercore HealthCONx Conference

    11/29 09:00 am

    GlobeNewswire Inc.

    Read more
  • TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

    11/21 07:00 am

    GlobeNewswire Inc.

    Read more
  • "Rule Breaker Investing" Market Cap Game Show: Bill Mann vs. Bill Barker

    06/27 01:55 pm

    The Motley Fool

    Read more
  • TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

    06/07 07:50 am

    GlobeNewswire Inc.

    Read more
  • TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

    06/03 07:30 am

    GlobeNewswire Inc.

    Read more
  • TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting

    05/31 07:30 am

    GlobeNewswire Inc.

    Read more
  • TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting

    05/28 07:30 am

    GlobeNewswire Inc.

    Read more
  • Wall Street Breakfast: The Week Ahead

    05/12 07:04 am

    Seeking Alpha

    Read more
  • Why TG Therapeutics Stock Was Rocketing Higher This Week

    05/03 05:56 am

    The Motley Fool

    Read more
  • TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates

    05/01 08:30 am

    Zacks Investment Research

    Read more
  • TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update

    04/30 04:55 pm

    GlobeNewswire Inc.

    Read more
  • After Plunging -9.82% in 4 Weeks, Here's Why the Trend Might Reverse for TG Therapeutics (TGTX)

    04/30 09:35 am

    Zacks Investment Research

    Read more
  • TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

    04/18 07:30 am

    GlobeNewswire Inc.

    Read more
  • TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis

    04/18 07:00 am

    GlobeNewswire Inc.

    Read more
  • TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

    04/15 07:30 am

    GlobeNewswire Inc.

    Read more
  • Should You Invest in the SPDR S&P Biotech ETF (XBI)?

    03/25 06:20 am

    Zacks Investment Research

    Read more
  • TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

    03/08 08:30 am

    GlobeNewswire Inc.

    Read more
  • Rare Stock Picks In February 2024 - From 32 Discerning Analysts

    03/05 11:00 am

    Seeking Alpha

    Read more
  • TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

    03/01 08:30 am

    GlobeNewswire Inc.

    Read more
  • Company News for Feb 29, 2024

    02/29 10:39 am

    Zacks Investment Research

    Read more
  • Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    02/28 03:02 pm

    Benzinga

    Read more
  • Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday

    02/28 12:37 pm

    Benzinga

    Read more
  • TG Therapeutics (TGTX) Reports Q4 Loss, Tops Revenue Estimates

    02/28 09:10 am

    Zacks Investment Research

    Read more
  • TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results

    02/28 08:00 am

    GlobeNewswire Inc.

    Read more
  • TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)

    02/27 08:30 am

    GlobeNewswire Inc.

    Read more
  • TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update

    02/23 08:30 am

    GlobeNewswire Inc.

    Read more
  • Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

    02/22 07:20 am

    Zacks Investment Research

    Read more
  • Will TG Therapeutics (TGTX) Report Negative Q4 Earnings? What You Should Know

    02/20 11:00 am

    Zacks Investment Research

    Read more
  • Bio-Rad Laboratories (BIO) Surpasses Q4 Earnings Estimates

    02/15 06:30 pm

    Zacks Investment Research

    Read more
  • Zimmer Biomet (ZBH) Q4 Earnings and Revenues Surpass Estimates

    02/08 08:40 am

    Zacks Investment Research

    Read more
  • HC Wainwright & Co. Maintains Buy Rating for TG Therapeutics: Here's What You Need To Know

    01/11 01:00 pm

    Benzinga

    Read more
  • Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    01/10 02:06 pm

    Benzinga

    Read more
  • Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday

    01/10 11:27 am

    Benzinga

    Read more
  • Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket

    01/10 09:02 am

    Benzinga

    Read more
  • PriceSmart Posts Upbeat Earnings, Joins SMART Global, Intuitive Surgical And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session

    01/10 06:18 am

    Benzinga

    Read more
  • Robinhood, Couchbase And 2 Other Stocks Insiders Are Selling

    01/09 09:07 am

    Benzinga

    Read more
  • TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

    01/05 08:30 am

    GlobeNewswire Inc.

    Read more
  • Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    12/06 03:43 pm

    Benzinga

    Read more
  • THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday

    12/06 11:48 am

    Benzinga

    Read more
  • TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference

    11/27 08:30 am

    GlobeNewswire Inc.

    Read more
  • Does TG Therapeutics (TGTX) Have the Potential to Rally 127.76% as Wall Street Analysts Expect?

    11/06 10:55 am

    Zacks Investment Research

    Read more
  • TG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) Conference

    11/03 07:30 am

    GlobeNewswire Inc.

    Read more
  • Dow Gains Over 100 Points; Fed Leaves Interest Rates Unchanged

    11/01 02:33 pm

    Benzinga

    Read more
  • Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    11/01 01:59 pm

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: